Landry Robert E

Avg. Two Year Performance

No purchase track record

6% Avg. Sale Return

3% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	< 1%	(2%)	7%	5%	6%
Sale Success Rate	6 of 12	6 of 12	4 of 12	3 of 12	3 of 12

Regeneron Pharmaceuticals I...

Drugs » Biotechnology

EVP Finance CFO:

Holdings: 23.96K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--